Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity.

[1]  David Julius,et al.  Cellular and Molecular Mechanisms of Pain , 2009, Cell.

[2]  Bruce Tidor,et al.  MIST: Maximum Information Spanning Trees for dimension reduction of biological data sets , 2009, Bioinform..

[3]  Christian Trautwein,et al.  Inflammatory Pathways in Liver Homeostasis and Liver Injury , 2009, Clinical reviews in allergy & immunology.

[4]  P. Ganey,et al.  Tumor Necrosis Factorα Is a Proximal Mediator of Synergistic Hepatotoxicity from Trovafloxacin/Lipopolysaccharide Coexposure , 2009, Journal of Pharmacology and Experimental Therapeutics.

[5]  Peter V. Henstock,et al.  Cellular imaging predictions of clinical drug-induced liver injury. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[6]  R Scott Obach,et al.  Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose. , 2008, Chemical research in toxicology.

[7]  P. Ganey,et al.  p38 Mitogen-Activated Protein Kinase-Dependent Tumor Necrosis Factor-α-Converting Enzyme Is Important for Liver Injury in Hepatotoxic Interaction between Lipopolysaccharide and Ranitidine , 2008, Journal of Pharmacology and Experimental Therapeutics.

[8]  D. Lauffenburger,et al.  An inducible autocrine cascade regulates rat hepatocyte proliferation and apoptosis responses to tumor necrosis factor‐α , 2008, Hepatology.

[9]  B. Antonsson,et al.  Mechanism of mitochondrial glutathione-dependent hepatocellular susceptibility to TNF despite NF-kappaB activation. , 2008, Gastroenterology.

[10]  G. Gores,et al.  Cellular and molecular mechanisms of liver injury. , 2008, Gastroenterology.

[11]  Defeng Wu,et al.  Cytochrome P4502E1 sensitizes to tumor necrosis factor alpha–induced liver injury through activation of mitogen‐activated protein kinases in mice , 2008, Hepatology.

[12]  J. Uetrecht.  Idiosyncratic drug reactions: past, present, and future. , 2008, Chemical research in toxicology.

[13]  P. Ganey,et al.  Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[14]  J. Luyendyk,et al.  The role of tumor necrosis factor alpha in lipopolysaccharide/ranitidine-induced inflammatory liver injury. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[15]  P. So,et al.  The FASEB Journal • Research Communication , 2007 .

[16]  A. Ross,et al.  Lipopolysaccharide opposes the induction of CYP26A1 and CYP26B1 gene expression by retinoic acid in the rat liver in vivo. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[17]  Mark R. Trusheim,et al.  Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers , 2007, Nature Reviews Drug Discovery.

[18]  J. Uetrecht,et al.  Idiosyncratic drug reactions: current understanding. , 2007, Annual review of pharmacology and toxicology.

[19]  Hayley S. Brown,et al.  Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies , 2007, Drug metabolism reviews.

[20]  J. Haskins,et al.  In vitro cytotoxicity assessment. , 2007, Methods in molecular biology.

[21]  P. Ganey,et al.  Modeling inflammation-drug interactions in vitro: a rat Kupffer cell-hepatocyte coculture system. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[22]  T. Luedde,et al.  Intracellular survival pathways in the liver , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[23]  Michael J Liguori,et al.  Modest Inflammation Enhances Diclofenac Hepatotoxicity in Rats: Role of Neutrophils and Bacterial Translocation , 2006, Journal of Pharmacology and Experimental Therapeutics.

[24]  David A. Brenner,et al.  Mechanisms of Liver Injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways , 2006 .

[25]  J. Lindon,et al.  Pharmaco-metabonomic phenotyping and personalized drug treatment , 2006, Nature.

[26]  P. Banks,et al.  Brief Communication: Severe Hepatotoxicity of Telithromycin: Three Case Reports and Literature Review , 2006, Annals of Internal Medicine.

[27]  G. Arteel,et al.  Metformin Prevents Endotoxin-Induced Liver Injury after Partial Hepatectomy , 2006, Journal of Pharmacology and Experimental Therapeutics.

[28]  R. Schwabe,et al.  Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[29]  L. Samson,et al.  A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction. , 2005, Current drug metabolism.

[30]  Neil Kaplowitz,et al.  Idiosyncratic drug hepatotoxicity , 2005, Nature Reviews Drug Discovery.

[31]  Terry S Peters,et al.  Do Preclinical Testing Strategies Help Predict Human Hepatotoxic Potentials? , 2005, Toxicologic pathology.

[32]  G. Hamilton,et al.  Isolation and culture of primary human hepatocytes. , 2005, Methods in molecular biology.

[33]  L. Griffith,et al.  Perfused Microreactors for Liver Tissue Engineering , 2005, 2005 IEEE Engineering in Medicine and Biology 27th Annual Conference.

[34]  J. Luyendyk,et al.  Adverse hepatic drug reactions: inflammatory episodes as consequence and contributor. , 2004, Chemico-biological interactions.

[35]  Dolores Diaz,et al.  Applications of cytotoxicity assays and pre-lethal mechanistic assays for assessment of human hepatotoxicity potential. , 2004, Chemico-biological interactions.

[36]  R. Andrade,et al.  Drug-induced hepatotoxicity , 2003, The New England journal of medicine.

[37]  J. Luyendyk,et al.  Ranitidine Treatment during a Modest Inflammatory Response Precipitates Idiosyncrasy-Like Liver Injury in Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.

[38]  J. Uetrecht,et al.  Screening for the potential of a drug candidate to cause idiosyncratic drug reactions. , 2003, Drug discovery today.

[39]  J V Castell,et al.  Human hepatocytes as a tool for studying toxicity and drug metabolism. , 2003, Current drug metabolism.

[40]  William M. Lee,et al.  Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States , 2002, Annals of Internal Medicine.

[41]  Elisabeth L. Humphris,et al.  Role of Toll-Like Receptors in Changes in Gene Expression and NF-κB Activation in Mouse Hepatocytes Stimulated with Lipopolysaccharide , 2002, Infection and Immunity.

[42]  J. Hoek,et al.  Ethanol, oxidative stress, and cytokine-induced liver cell injury. , 2002, Alcohol.

[43]  S. Bursian,et al.  Underlying endotoxemia augments toxic responses to chlorpromazine: is there a relationship to drug idiosyncrasy? , 2002, The Journal of pharmacology and experimental therapeutics.

[44]  P Smith,et al.  Concordance of the toxicity of pharmaceuticals in humans and in animals. , 2000, Regulatory toxicology and pharmacology : RTP.

[45]  L. Schook,et al.  Acute hepatotoxicant exposure induces TNFR-mediated hepatic injury and cytokine/apoptotic gene expression. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[46]  M. Mattson,et al.  Hepatic cytochrome P-450 expression in tumor necrosis factor-alpha receptor (p55/p75) knockout mice after endotoxin administration. , 1999, The Journal of pharmacology and experimental therapeutics.

[47]  E. S. Fox,et al.  LPS-mediated NF-kappa beta activation in rat Kupffer cells can be induced independently of CD14. , 1996, The American journal of physiology.

[48]  C. Lowenstein,et al.  Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Sidney Addelman,et al.  trans-Dimethanolbis(1,1,1-trifluoro-5,5-dimethylhexane-2,4-dionato)zinc(II) , 2008, Acta crystallographica. Section E, Structure reports online.